OpenVSafe by OpenVAERS
Search V-safe

DG2-23745-85034

2 vaccinations 4 coded responses 24 check-ins 4 free-text entries 2 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
840 / UT
Registered
2021-03-16
Relationship
Self
Race
N/A
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-16
    Registered in v-safe
  2. 2021-03-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-06
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-06
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-20
    Survey response — day 14, dose 2
    MedDRA: Headache, Pain — Feeling: Fair
    Free text: Headaches and some minor aches and pain. Nothing serious
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-04
    Survey response — day 28, dose 2
    MedDRA: Excessive granulation tissue, Macular oedema, Office visit, Ophthalmic migraine, Scar, Visual impairment — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Continuing ocular migraine symptoms well beyond customary duration. Saw ophthalmologist about diminished vision. Dr Identified macular swelling and residual scar tissue. Cause unknown. · Healthcare visit (other): Complete eye exam, retinal scans and photos.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-04
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-05-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-06
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-10-05
    Survey response — 6 months, dose 2
    MedDRA: Hypertension, Macular oedema, Macular scar, Office visit, Ophthalmic migraine, Optical coherence tomography abnormal, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: High blood pressure and now taking 100mg Lozartin. Increase ocular migraine events. Retina/ macula scans discovered some swelling and scarring on both right and left macula with no known reason or cause. Some small center of vision voids discovered · Healthcare visit (other): Multiple visits to ophthalmologist
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-05
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2021-10-06
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  30. 2022-04-06
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school
    Free text: Was tested and confirmed infected with COVID-19 on October 29, 2021
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Pfizer-BioNTech
22021-04-06Pfizer-BioNTech

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — day 14, dose 2

2021-04-20

Symptoms: Headaches and some minor aches and pain. Nothing serious

Release 8 — day 28, dose 2

2021-05-04

Symptoms: Continuing ocular migraine symptoms well beyond customary duration. Saw ophthalmologist about diminished vision. Dr Identified macular swelling and residual scar tissue. Cause unknown.
Healthcare visit (other): Complete eye exam, retinal scans and photos.

Release 10 — 6 months, dose 2

2021-10-05

Symptoms: High blood pressure and now taking 100mg Lozartin. Increase ocular migraine events. Retina/ macula scans discovered some swelling and scarring on both right and left macula with no known reason or cause. Some small center of vision voids discovered cut off by CDC
Healthcare visit (other): Multiple visits to ophthalmologist

Release 11 — 12 months, dose 2

2022-04-06

Symptoms: Was tested and confirmed infected with COVID-19 on October 29, 2021

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDCOVID-19 · · ✓
SDExcessive granulation tissue ○ ✓ ○
SDHeadache ✓ ✓ ✓
SDHypertension · · ✓
SDMacular oedema ✓ ✓ ✓
SDMacular scar · · ✓
SDOffice visit ✓ · ✓
SDOphthalmic migraine ✓ ✓ ✓
SDOptical coherence tomography abnormal · · ✓
SDPain ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SDScar ✓ · ✓
SDVisual impairment ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release